Omicron News and Research

RSS
US blood donor study finds nearly half of population exhibits hybrid immunity to COVID-19

US blood donor study finds nearly half of population exhibits hybrid immunity to COVID-19

Lymphoid depletion associated with suppressed APC function characterizes the lethality of COVID-19 in mice

Lymphoid depletion associated with suppressed APC function characterizes the lethality of COVID-19 in mice

Key insights into immune responses after COVID-19 vaccination in Indigenous people

Key insights into immune responses after COVID-19 vaccination in Indigenous people

The association between COVID-19 vaccination types and doses with adverse outcomes of SARS-CoV-2

The association between COVID-19 vaccination types and doses with adverse outcomes of SARS-CoV-2

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

Experimental decoy provides long-term protection from SARS-Cov-2 infection

Experimental decoy provides long-term protection from SARS-Cov-2 infection

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Defining long-COVID using self-reported symptoms

Defining long-COVID using self-reported symptoms

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Large study uncovers new details about long COVID

Large study uncovers new details about long COVID

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

RECOVER study: An important step toward defining long COVID

RECOVER study: An important step toward defining long COVID

Study elucidates 12 defining symptoms of long COVID

Study elucidates 12 defining symptoms of long COVID

Pawsitive test: Dogs sniff out COVID-19 with high accuracy, study shows

Pawsitive test: Dogs sniff out COVID-19 with high accuracy, study shows

The adaptive immunity of human endemic viruses

The adaptive immunity of human endemic viruses

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research finds fever to be the most common non-respiratory feature of SARS-CoV-2 infection

Research finds fever to be the most common non-respiratory feature of SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.